BENDAMUSTINE ARROW 2.5 mg/ml, powder for concentrate for infusion 5 bottles, CIP 3400955095675
Active ingredients: Bendamustine hydrochloride monohydrate, Bendamustine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusion5 bottles, CIP 3400955095675intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENDAMUSTINE ARROW 2,5 mg/mL, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre jaune(brun) de 25 mg de poudre
- Marketing authorisation holder
- EUGIA PHARMA (MALTA) (MALTE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Aug 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61826343CIP75509567CIP133400955095675Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BENDAMUSTINE (CHLORHYDRATE DE) MONOHYDRATÉpoudre | — | SA |
| CHLORHYDRATE DE BENDAMUSTINEpoudre | 25 mg · un flacon de 20 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.